SEC Form 4 · accession 0001567619-19-001237
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brett Sandercock
Officer — Chief Financial Officer
Period of report
Jan 15, 2019
Accepted (ET)
Jan 16, 2019 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Jan 15, 2019 | S | 2,000 | $114.18 | D | 94,390 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The transaction was conducted under a Rule 10b5-1 Plan.